Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunshine Labs
Victoria, British Columbia, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Sunshine Labs supplies pharmaceutical-grade controlled substances (psilocybin, MDMA, morphine, diacetylmorphine, cocaine, opium, methamphetamine) for research, medical use and clinical trials internationally. Clinical validation is ongoing or supportive rather than wholly proprietary; partnerships with clinics and device manufacturers are central.
- Therapeutic areas
- Psychiatry
- Modalities
- Small moleculePsychedelicBiologic
- Industry
- Biotech
02
Partnerships
Speranza Therapeutics (medical device/harm reduction partnership)Optimi Health Corp. (related supply and research partnerships)
Beyond the preview
Go deeper on Sunshine Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sunshine Labs.